HomeACADEMIA
ACADEMIA

Japan Esophageal Society to Recommend 5-FU + Cisplatin as 1st-Line Therapy for Esophageal Cancer in New Guidelines
(Jul.7.2016)

The Japan Esophageal Society (JES) plans to recommend the combination of 5-FU (fluorouracil) and cisplatin as first-line therapy for unresectable or recurrent esophageal cancer, the society revealed at its annual meeting on July 6. The JES plans to include this ...
(LOG IN FOR FULL STORY)